Skip to main content
Hit enter to search or ESC to close
Close Search
AccessDx Laboratory
  • Order Testing
Menu
  • Providers
    • Testing Offerings
      • Pharmacogenomics (PGx)
      • Hereditary Cancer
      • Infectious Disease
    • Programs
      • Medication Safety Program for LTPACs
  • Patients & Families
  • About
    • Contact Us
    • Newsroom
    • Events
    • Careers
  • Provider Portal
  • Patient Portal
  • Order Testing
  • Providers
    • Testing Offerings
      • Pharmacogenomics (PGx)
      • Hereditary Cancer
      • Infectious Disease
    • Programs
      • Medication Safety Program for LTPACs
  • Patients & Families
  • About
    • Contact Us
    • Newsroom
    • Events
    • Careers
  • Provider Portal
  • Patient Portal
  • twitter
  • x-twitter
  • linkedin
PGxperts™ Bytes: Maternal Mental Health
News

PGxperts™ Bytes: Maternal Mental Health

InterVenn Biosciences Partners with Aranscia
News

InterVenn Biosciences Partners with Aranscia

PGxperts™ Bytes: Medication Safety, Survey Readiness, and the Role of PGx in Long-Term Care
News

PGxperts™ Bytes: Medication Safety, Survey Readiness, and the Role of PGx in Long-Term Care

PGxperts™ Bytes: The Case for DPYD Testing
News

PGxperts™ Bytes: The Case for DPYD Testing

DPYD Safety Update: Reducing the Risk of Critical or Fatal Chemotherapy Side Effects
News

DPYD Safety Update: Reducing the Risk of Critical or Fatal Chemotherapy Side Effects

AccessDx Lab to Exhibit at ASCP 2025
ConferenceNews

AccessDx Lab to Exhibit at ASCP 2025

AccessDx Lab to Exhibit at NCDONA 2025 Icon of South Carolina
ConferenceNews

AccessDx Lab to Exhibit at NCDONA 2025

Personalized prescribing in long-term care: Why it matters more than ever
News

Personalized prescribing in long-term care: Why it matters more than ever

PGxperts™ Bytes: Selecting a Quality PGx Partner
News

PGxperts™ Bytes: Selecting a Quality PGx Partner

Spartanburg Regional Healthcare System (SRHS) Selects AccessDx Laboratory as Pharmacogenomics (PGx) Program Partner
News

Spartanburg Regional Healthcare System (SRHS) Selects AccessDx Laboratory as Pharmacogenomics (PGx) Program Partner

  • 1
  • 2
  • 3
  • …
  • 5
  • Next

Recent Posts

  • PGxperts™ Bytes: Maternal Mental Health
  • InterVenn Biosciences Partners with Aranscia
  • PGxperts™ Bytes: Medication Safety, Survey Readiness, and the Role of PGx in Long-Term Care
  • PGxperts™ Bytes: The Case for DPYD Testing
  • DPYD Safety Update: Reducing the Risk of Critical or Fatal Chemotherapy Side Effects

Recent Comments

    Popular Posts

    • Pharmacogenomic Testing as a Preventive Approach to Tardive Dyskinesia Risk Reduction and Management May 5, 2025
    • AccessDx Lab to Exhibit at the 2024 PointClickCare SUMMIT January 24, 2025
    • AccessDx Lab to Exhibit at the 2024 Psych Congress October 1, 2024

    Recent Posts

    • PGxperts™ Bytes: Maternal Mental Health January 23, 2026
    • InterVenn Biosciences Partners with Aranscia January 7, 2026
    • PGxperts™ Bytes: Medication Safety, Survey Readiness, and the Role of PGx in Long-Term Care January 6, 2026

    CLIA-certified, CAP-accredited, NYSDOH-approved, and fully compliant with HIPAA and FDA standards.

    Legal

    Address

    AccessDx Laboratory, LLC
    4035 Willowbend Blvd. Suite 400
    Houston, TX 77025

    Connect

    T: 888-958-2298
    E: [email protected]

    © 2026 AccessDx Laboratory.

    • linkedin